Q2 EPS Forecast for Aquestive Therapeutics Cut by Analyst
Aquestive Therapeutics, Inc. (NASDAQ:AQST – Free Report) – Analysts at HC Wainwright reduced their Q2 2025 earnings per share estimates for Aquestive Therapeutics in a report released on Thursday, May 15th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings of ($0.22) per share for the quarter, down from their prior […]
